Mostafa M M El-Miligy

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Molecular Docking

Tyrosine Kinase

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Marwa E Abdelaziz, Mostafa M M El-Miligy, Salwa M Fahmy, Marwa M Abu-Serie, Aly A Hazzaa, Mona A Mahran
Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mostafa M M El-Miligy, Ahmed K Al-Kubeisi, Rasha A Nassra, Saad R El-Zemity, Aly A Hazzaa
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Marwa E Abdelaziz, Mostafa M M El-Miligy, Salwa M Fahmy, Marwa M Abu-Serie, Aly A Hazzaa, Mona A Mahran
Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Marwa E Abdelaziz, Mostafa M M El-Miligy, Salwa M Fahmy, Marwa M Abu-Serie, Aly A Hazzaa, Mona A Mahran
Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mostafa M M El-Miligy, Ahmed K Al-Kubeisi, Rasha A Nassra, Saad R El-Zemity, Aly A Hazzaa
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mostafa M M El-Miligy, Ahmed K Al-Kubeisi, Rasha A Nassra, Saad R El-Zemity, Aly A Hazzaa
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mostafa M M El-Miligy, Ahmed K Al-Kubeisi, Rasha A Nassra, Saad R El-Zemity, Aly A Hazzaa
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Marwa E Abdelaziz, Mostafa M M El-Miligy, Salwa M Fahmy, Marwa M Abu-Serie, Aly A Hazzaa, Mona A Mahran
Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mostafa M M El-Miligy, Marwa E Abdelaziz, Salwa M Fahmy, Tamer M Ibrahim, Marwa M Abu-Serie, Mona A Mahran, Aly A Hazzaa
Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mostafa M M El-Miligy, Marwa E Abdelaziz, Salwa M Fahmy, Tamer M Ibrahim, Marwa M Abu-Serie, Mona A Mahran, Aly A Hazzaa
Discovery of new pyridine-quinoline hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mostafa M M El-Miligy, Ahmed K Al-Kubeisi, Mohamed G Bekhit, Saad R El-Zemity, Rasha A Nassra, Aly A Hazzaa
Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2022)
Nada H El-Dershaby, Soad A El-Hawash, Shaymaa E Kassab, Hoda G Daabees, Ahmed E Abdel Moneim, Mostafa M M El-Miligy
Rational Design and Synthesis of New Selective COX-2 Inhibitors with In Vivo PGE2-Lowering Activity by Tethering Benzenesulfonamide and 1,2,3-Triazole Pharmacophores to Some NSAIDs. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)